Introduction on “Next Generation Biologics

09:50 - 10:25

  • New therapeutic approaches
  • Treatment of severe disease on genetic roots
  • An introduction on innovative approaches, opportunities and challenges.

Carsten Olbrich, Product Quality Steward Eylea and Anetumab Ravstantine , Bayer